Nomination Committee of the Annual General Meeting 2025
In accordance with the resolution passed by Elekta’s Annual General Meeting on September 5, 2024, the Chairman of the Board has convened the Nomination Committee for the Annual General Meeting 2025 by contacting the company’s largest shareholders in terms of votes, in addition to the shareholder or shareholders represented by the Chairman himself. The procedure is described in detail in the notice to the Annual General Meeting 2024.
The Nomination Committee for the AGM 2025 consist of:
- Laurent Leksell (Chair of the Nomination Committee), in his capacity as Chairman of the Board of Elekta and representing his own and related parties’ holdings
- Thomas Wuolikainen, appointed by the Fourth Swedish National Pension Fund
- Katarina Hammar, appointed by Nordea Funds
- Patrik Jönsson, appointed by SEB Funds
- Jesper Bergström, appointed by Handelsbanken
The task of the Nomination Committee is to present the following proposals for resolution:
- Chairman of the Annual General Meeting of Shareholders;
- Chairman of the Board of Directors and other members of the Board of Directors;
- fees to the Board of Directors;
- external auditor and fees to the auditor; and where deemed necessary; and
- proposal to amend the procedure for the Nomination Committee.
The Nomination Committee proposes that the Annual General Meeting 2025 resolves to reelect Laurent Leksell, Ann Costello, Tomas Eliasson, Jan Kimpen, Wolfgang Reim, Jan Secher, Volker Wetekam and Cecilia Wikström, and to elect Jan De Witte, as Directors of the Board of Directors for the period until the end of the next Annual General Meeting. Furthermore, the Nomination Committee proposes that Laurent Leksell is reelected as the Chairman of the Board of Directors.
Jan De Witte is a seasoned executive with more than 25 years of experience in the global technology and life science industries. As the former CEO for Integra LifeSciences, a U.S.-based global leader in neurosurgery and regenerative technologies, between 2021-2024, and for Belgian Barco, a leading global advanced visualization technology company, between 2016-2021, Jan De Witte will bring relevant and extensive leadership expertise both from an industry as well as a regional perspective. Before taking on CEO roles, he held various global senior-level leadership roles at GE HealthCare, spanning hardware, software and services business segments in medtech and healthtech. Jan De Witte’s career began with foundational roles as senior strategy consultant at McKinsey in Europe, and operations at Procter & Gamble in Belgium. Jan De Witte currently serves as an operating partner at GHO Capital Partners, a European healthcare specialist private equity investor, as well as on the Board of Directors of ResMed, a global company focusing on sleep health. Jan de Witte holds a Bachelor’s and Master of Science degree in electromechanical engineering from the KU Leuven in Belgium and a Master of Business Administration from Harvard Business School. He is a Belgian citizen, resides in Kortrijk, Belgium, and was born in 1964.
The Nomination Committee’s complete proposal was published in connection with the convening of Elekta’s Annual General Meeting 2025, held on September 4, 2025.